Liraglutide (Saxenda)
GLP-1 Receptor Agonist class · 6 generic manufacturers · 8 ANDAs filed at FDA.
$383.1M in CY2024 Part D spend457K claims · 170K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Liraglutide used for?
Liraglutide is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Liraglutide?
Yes. 8 ANDAs filed at FDA, 6 generic manufacturers currently shipping.
How much does my plan pay for Liraglutide?
Across 329 Part D plans, Liraglutide averages $46.67/unit (NADAC). Lowest available: $30.63/unit. Highest in distribution: $87.82/unit.
Is Liraglutide on the FDA shortage list?
Yes. Liraglutide is currently listed as an active FDA shortage.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (12 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.